G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 94 filers reported holding G1 THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $90,000 | -39.6% | 11,849 | -19.1% | 0.00% | – |
Q4 2021 | $149,000 | -21.2% | 14,647 | +4.1% | 0.00% | -100.0% |
Q3 2021 | $189,000 | -51.4% | 14,070 | -20.6% | 0.00% | 0.0% |
Q2 2021 | $389,000 | +8.4% | 17,730 | +18.9% | 0.00% | 0.0% |
Q1 2021 | $359,000 | +48.3% | 14,910 | +11.1% | 0.00% | 0.0% |
Q4 2020 | $242,000 | +103.4% | 13,425 | +30.2% | 0.00% | 0.0% |
Q3 2020 | $119,000 | -54.1% | 10,309 | -3.4% | 0.00% | 0.0% |
Q2 2020 | $259,000 | -22.9% | 10,668 | -16.1% | 0.00% | -50.0% |
Q4 2019 | $336,000 | +5.3% | 12,714 | -9.3% | 0.00% | 0.0% |
Q3 2019 | $319,000 | -22.4% | 14,011 | +4.6% | 0.00% | 0.0% |
Q2 2019 | $411,000 | +62.5% | 13,391 | -12.1% | 0.00% | 0.0% |
Q1 2019 | $253,000 | -11.8% | 15,231 | +1.5% | 0.00% | 0.0% |
Q4 2018 | $287,000 | -66.1% | 15,003 | -7.2% | 0.00% | -66.7% |
Q3 2018 | $846,000 | +18.5% | 16,171 | -1.6% | 0.01% | +20.0% |
Q2 2018 | $714,000 | +29.6% | 16,431 | +10.4% | 0.01% | +25.0% |
Q1 2018 | $551,000 | +69.0% | 14,877 | -9.5% | 0.00% | +100.0% |
Q4 2017 | $326,000 | – | 16,438 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birchview Capital, LP | 120,000 | $172,800 | 0.15% |
DENALI ADVISORS LLC | 148,800 | $214,272 | 0.08% |
XTX Topco Ltd | 296,601 | $427,105 | 0.07% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 234,000 | $336,960 | 0.06% |
LEVEL FOUR ADVISORY SERVICES, LLC | 183,400 | $264,096 | 0.02% |
Curi Wealth Management, LLC | 70,742 | $101,869 | 0.02% |
FRANKLIN STREET ADVISORS INC /NC | 83,400 | $120 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 140,000 | $201,600 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 573,256 | $825,489 | 0.01% |
ALGERT GLOBAL LLC | 68,100 | $98 | 0.01% |